ProMIS Neurosciences Ret. on assets
What is the Ret. on assets of ProMIS Neurosciences?
The Ret. on assets of ProMIS Neurosciences, Inc. is -55.17%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on OTC compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with ret. on assets similar to ProMIS Neurosciences
- eve Sleep plc has Ret. on assets of -55.28%
- Portola Pharmaceuticals has Ret. on assets of -55.28%
- Rex Resources has Ret. on assets of -55.25%
- Steer Technologies Inc has Ret. on assets of -55.24%
- T2 Biosystems has Ret. on assets of -55.24%
- City Chic Collective has Ret. on assets of -55.21%
- ProMIS Neurosciences has Ret. on assets of -55.17%
- Four Nines Gold has Ret. on assets of -55.16%
- AssetOwl has Ret. on assets of -55.15%
- Nevada Metals has Ret. on assets of -55.13%
- Thunder Mountain Gold has Ret. on assets of -55.12%
- Versus Systems has Ret. on assets of -55.12%
- Pan Andean Minerals has Ret. on assets of -55.07%